Rectal indomethacin was compared with placebo in a randomised, double-blind study of 100 patients undergoing spinal surgery, in which postoperative pain scores, pethidine, diazepam and metoclopramide consumption, bleeding time, blood loss and oral fluid and food tolerance were measured. Side-effects of indomethacin and pethidine were compared in the two groups. In the indomethacin group, pain scores were significantly less for all measurements made during the first three postoperative days, pethidine and diazepam consumption were significantly less on all three days, bleeding time was significantly increased, although still within the clinically normal range, intraoperative and postoperative blood losses were not significantly affected, coagulation was not significantly impaired as assessed clinically, patients tolerated oral feeding significantly earlier, there was no significant increase in the incidence of gastro-intestinal side-effects except for diarrhoea, and there was no significant reduction in the incidence of side-effects associated with the use of pethidine.
Recent studies have demonstrated the effectiveness of the non-steroidal antiinflammatory drugs (NSAIDs) indomethacin 1.4, diclofenac,5.10 ibuprofen,11 ketorolac,12 indoprofen,13 naproxen,14 lysine acetylsalicylate, I 5 dipyrone, 16 meclofenamate l7 and acetaminophen I 7 in the management of postoperative pain, although three studies l8 • 20 using diclofenac were unable to demonstrate this effect.
On the basis that indomethacin is indicated for inflammation, pain and oedema following orthopaedic surgical procedures, its routine use was commenced in patients undergoing spinal surgery and was found to be of such apparent value that a clinical trial was undertaken to confirm this bias. The rectal route of delivery was chosen as it is not affected by nausea and vomiting and because of the ease of drug administration. No information is available regarding uptake of indomethacin following rectal administration: however, after oral ingestion peak concentrations are not attained for three hours. 21 Furthermore, NSAIDs are not effective against previously released mediators of pain, their action being to prevent the de novo release of prostaglandins. 22 It seemed prudent, therefore, to administer the suppositories prior to the commencement of surgery in order to allow therapeutic levels of indomethacin to be achieved early in the perioperative period, thereby limiting the formation of prostaglandins.
While intermittent intramuscular injections of opioid are not as effective as opioid infusions,23 especially patient-controlled infusions,24 it was considered that a clearer picture of patient requirements would be obtained by using intermittent intramuscular injections, in the absence of patient-controlled infusors in our hospital.
Although NSAIDs are considered to have fewer side-effects than the opioids, there are two potentially serious concerns, those of haemostasis and gastro-intestinal lesions, on which our study concentrated. Studies which have considered the anti-platelet effect of NSAIDs include those of Owen,11 which reported that intra-operative blood loss and postoperative wound bruising were unaffected, without providing any data, Hodsman, 5 which demonstrated a decrease in platelet count, Buchanan, 6 which showed no increase in operative blood loss, and Rorarius 25 in which bleeding time was prolonged, although mean values were normal.
There is little useful information available on the incidence of gastro-intestinal side-effects associated with short-term use of NSAIDs following surgery.
The principal aims of the study were to examine whether indomethacin was useful in the management of post-spinal surgery pain and to determine whether the drug's side-effects, especially in relation to haemostasis, were of significance.
MATERIALS AND METHODS
Written, informed consent was obtained from one hundred consecutive patients scheduled for spinal surgery who were randomly allocated by the hospital pharmacist to receive suppositories containing indomethacin 100 mg (n = 50) or placebo (n = 50). The suppositories were identical in appearance and constituency apart from the active drug. The study, which was approved by the Hospital Ethics Committee, was double-blind, with only the pharmacist aware of the identity of the suppositories.
Patients excluded were those with a history of peptic ulceration, indomethacin intolerance, NSAID allergy, bleeding disorders, anticoagulant therapy, pethidine, diazepam or metoclopramide sensitivity, epilepsy, Parkinsonism, renal or hepatic insufficiency, lithium or diflunisal therapy, rectal or anal disease and those who refused to participate. Patients had the right to withdraw from the trial at any time at their request and the investigators would withdraw any patient who was believed to be adversely affected by the trial suppositories.
Premedication, technique of anaesthesia and postoperative management were standardised. Premedication consisted of pethidine 1.0-1.5 mg/kg IM, diazepam 5-15 mg (weight based on a sliding scale) orally, metoclopramide 10 mg IM, and two suppositories, all one hour preoperatively. Anaesthesia consisted of thiopentone 4-6 mg/kg, vecuronium 0.1-0.15 mg/kgor alcuronium 0.25-0.3 mg/kg, halothane or enflurane in concentrations as considered appropriate, and nitrous oxide. Reversal was performed with standard doses of atropine and neostigmine. Postoperatively patients were ordered pethidine two-hourly pm and diazepam four-hourly pm in the same doses as preoperatively, metroclopromide 10 mg fourhourly p.Ln. and one trial suppository twelvehourly for 72 hours. Diazepam was administered when required for control of spasm of spinal musculature.
The patients were located in the same ward area and supervised by one of us (A.R.). Nursing staff were encouraged to administer pethidine liberally and advised not to use the drug for sedation or in anticipation of pain developing. At the time of surgery, the operative blood loss was recorded by the anaesthetist and an assessment of haemostasis made by the surgeon as either normal or abnormal. Bleeding time measurements were made on the morning of the first postoperative day. Pain scores were recorded on a standard 100 mm visual analogue scale. Oral fluid and food tolerance and wound haematomata were assessed as either present or absent. If a drain was inserted into the operative site, a collection bottle was attached and the volume of drainage recorded. These observations were recorded by nursing staff twelve-hourly for 72 hours.
STATISTICAL ANALYSIS
All P values in Tables 4-6, 8-9 refer to the testing of the null hypothesis of no difference between the Indomethacin and placebo groups.
The Wilcoxon Rank Sum Test 26 was used for comparing the groups with respect to the continuous variables (visual analogue scores, pethidine consumption, diazepam consumption, operative blood loss, postoperative wound drainage, bleeding time, metoclopramide consumption, time to fluid and to food tolerance). For those variables which were measured repeatedly over time (visual analogue scores, pethidine, diazepam and metoclopramide consumption), the groups were compared at the specified time points. The Wilcoxon test was used in preference to the t-test because the assumption that the variables were normally distributed was not appropriate.
Fisher's Exact Test 26 was used for comparing the groups with respect to the discrete variables, namely, the proportion with abnormal intraoperative coagulation, as assessed by the surgeon, and the proportions with the various side-effects.
RESULTS
Of the one hundred patients who entered the trial, twelve were withdrawn for reasons shown in Table 1 . Of the remainder, 43 received indomethacin and 45 placebo suppositories. The two groups were well matched with respect to age, weight and sex distribution ( Table 2 ) and to operation types (Table 3) .
Mean pain scores throughout the three postoperative days were significantly less in the indomethacin group (Table 4 ).
Both pethidine (Table 5 ) and diazepam (Table 6 ) consumption were significantly less in the indomethacin group on each of the three postoperative days.
While the operative and postoperative blood losses showed no significant differences between The mean bleeding time was significantly longer in the indomethacin group although within the normal clinical range ( Table 7) .
Metoclopramide consumption was similar in the two groups (Table 8 ).
There were no wound haematomata in either group.
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The indomethacin group was able to tolerate solids significantly earlier than the placebo group, but no difference was detected with oral fluid (SD) (10) 
Dyspepsia occurred significantly more frequently in the placebo group (15/45 compared with 5/43 in the indomethacin group, P = 0.02) and diarrhoea significantly more frequently in the indomethacin group (20/43 compared with 11145 in the placebo group, P= 0.04).
No patient in either group developed gastrointestinal tract bleeding or respiratory depression.
There was no significant difference between the two groups in the incidence of nausea (indomethacin 12/43, placebo 15/45) or vomiting (indomethacin 6/43, placebo 8/45).
DISCUSSION
The results of this study reveal substantial reductions in pain scores and total opioid consumption in the indomethacin group, which is consistent with the accepted benefits of the drug in the management of musculoskeletal pain.
The mean total dose of pethidine was significantly less in the indomethacin group which is in accordance with our previous impressions. The marked differences between the group's pain scores and pethidine and diazepam consumption, even on the third postoperative day, indicates the value of continuing indomethacin therapy for several days in the postoperative period, especially considering that the drug has a plasma half-life of 2.6 hours. 27 Although the results for diazepam consumption reached statistical significance, their clinical relevance is questionable. Nevertheless, the results support the pain score information as muscle spasm, for which diazepam was prescribed, is directly related to wound pain.
The results relating to haemostasis are in conformity with large studies in which it has been difficult to prove that the anti-platelet effect of NSAIDs leads to increased risk of intra-operative and postoperative bleeding. 28 However, in a diclofenac study5 there were two patients, both of whom had had extensive pelvic dissection, who required re-operation because of postoperative bleeding. In another study using indomethacin after major abdominal surgery, there were two wound haematomata, one haematemesis and one 
P value 0.29 0.005* wound haemorrhage. I In our study there was one patient who required evacuation of a large, potentially serious epidural haematoma. This patient, who was withdrawn from the study, had been using placebo suppositories.
Although the indomethacin group's mean bleeding time reached statistical significance compared with that of the placebo group, it was still well within the normal range. While less than onequarter of the indomethacin group were thought by the operating surgeon to have abnormal coagulation, the results achieved statistical significance. However, this was not reflected in the operative blood loss statistics.
Side-effects of indomethacin may result from lesions throughout the entire gastro-intestinal tract. Our study revealed a higher incidence of dyspepsia in the placebo group, although only just achieving statistical significance. That indomethacin may exert a protective effect on the upper gastrointestinal tract is highly improbable. However, the results support the contention by some that rectal administration of indomethacin is less likely to produce gastroduodenal ulceration than if given orally, although it is acknowledged that indomethacin's action is mainly systemic due to depression of the biosynthesis of mucopolysaccharides through its antiprostaglandin properties.
In view of the incidence of diarrhoea being high in both study groups and just reaching statistical significance in the indomethacin group, it was considered that the other constituents of the suppositories may have been largely responsible, rather than the indomethacin itself. Previous and subsequent use of standard indomethacin suppositories support this point of view.
Despite the fact that higher mean doses of pethidine were used in the placebo group, there was no increase in the incidence of nausea or vomiting. This confirms the findings of other similar studies. 1, 2, 7, 19 In support of this the consumption of the anti-emetic metoclopramide was similar in the two groups. In contrast, however, and of clinical importance, the indomethacin group tolerated food twelve hours earlier than the placebo group.
In conclusion, this study has demonstrated the value of indomethacin for the relief of pain and muscle spasm following spinal surgery. Not only was the pethidine requirement much less when indomethacin was used, but the quality of pain relief was considerably better. Concerns regarding the anti-platelet activity of indomethacin have been shown to be theoretically correct but clinically insignificant.
